Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jul 26:2018:6873276.
doi: 10.1155/2018/6873276. eCollection 2018.

Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review

Hidekazu Ikeuchi  1 , Kana Koinuma  1 , Masao Nakasatomi  1 , Toru Sakairi  1 , Yoriaki Kaneko  1 , Akito Maeshima  1 , Yuichi Yamazaki  2 , Hiroaki Okamoto  3 , Toshihide Mimura  4 , Satoshi Mochida  5 , Yoshihisa Nojima  6 , Keiju Hiromura  1
Affiliations
Case Reports

Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review

Hidekazu Ikeuchi et al. Case Rep Rheumatol. .

Abstract

Hepatitis E is an acute self-limiting disease caused by hepatitis E virus (HEV). Recent reports show that HEV can induce chronic hepatitis or be reactivated in immunocompromised hosts. We report a 63-year-old woman with rheumatoid arthritis (RA) who developed hepatitis E during treatment with tocilizumab. Analysis of serially stocked serum samples confirmed that hepatitis was caused by primary infection with HEV and not by viral reactivation. Her liver function improved after discontinuing tocilizumab and remained within the normal range without reactivation of HEV for >5 years after restarting tocilizumab. We also reviewed the published cases of hepatitis E that developed during RA treatment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Saag K. G., Teng G. G., Patkar N. M., et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis and Rheumatism. 2008;59(6):762–784. doi: 10.1002/art.23721. - DOI - PubMed
    1. Singh J. A., Saag K. G., Bridges S. L., Jr., et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis and Rheumatology. 2016;68(1):1–26. doi: 10.1002/art.39480. - DOI - PubMed
    1. Kamar N., Selves J., Mansuy J. M., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. New England Journal of Medicine. 2008;358(8):811–817. doi: 10.1056/nejmoa0706992. - DOI - PubMed
    1. Dalton H. R., Bendall R. P., Keane F. E., Tedder R. S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. The New England Journal of Medicine. 2009;361(10):1025–1027. doi: 10.1056/nejmc0903778. - DOI - PubMed
    1. le Coutre P., Meisel H., Hofmann J., et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut. 2009;58(5):699–702. doi: 10.1136/gut.2008.165571. - DOI - PubMed

Publication types

LinkOut - more resources